Neural cell adhesion molecule-180 expression as a prognostic criterion in colorectal carcinoma: Feasible or not?

Table 1 Background of 26 cases of resected colorectal carcinoma

Case	Gender	Age (yr)	Location	Tumour
1	F	49	Colon	Adenocarcinoma
2	F	70	Rectum	Adenocarcinoma
3	M	86	Colon	Adenocarcinoma
4	M	76	Colon	Adenocarcinoma
5	M	73	Colon	Adenocarcinoma
6	F	76	Colon	Adenocarcinoma
7	M	72	Colon	Adenocarcinoma
8	F	68	Colon	Adenocarcinoma
9	M	72	Colon	Adenocarcinoma
10	M	50	Rectum	Adenocarcinoma
11	M	88	Colon	Adenocarcinoma
12	F	68	Rectum	Adenocarcinoma
13	F	48	Colon	Adenocarcinoma
14	F	75	Rectum	Adenocarcinoma
15	M	37	Rectum	Adenocarcinoma
16	M	57	Rectum	Adenocarcinoma
17	F	71	Colon	Adenocarcinoma
18	M	70	Colon	Adenocarcinoma
19	M	47	Colon	Adenocarcinoma
20	M	47	Colon	Adenocarcinoma
21	F	71	Colon	Adenocarcinoma
22	M	53	Colon	Adenocarcinoma
23	M	80	Rectum	Adenocarcinoma
24	F	49	Rectum	Adenocarcinoma
25	M	76	Colon	Adenocarcinoma
26	M	62	Rectum	Adenocarcinoma

Table 2 Results of histopathologic evaluation and flow cytometric analysis of NCAM-180 status

Case	pTNM	Stage	Histology	NCAM-180	Outcome
1	T3N0M0	II	Moderate	-	No active disease at 21 mo follow-up
2	T4N1M1	IV	Poor	-	Died of metastatic diesease 8 mo postresection
3	T4N2M1	IV	Moderate	-	No active disease at 9 mo follow-up
4	T3N0M0	II	Well	-	No active disease at 20 mo follow-up
5	T4NIM1	IV	Poor	-	Died of cardiopulmonary complication postoperatively
6	T3N1M0	III	Moderate	-	No active disease at 6 mo follow-up
7	T2N0M0	I	Moderate	-	Metachrone colonic disease at 15 mo
8	T2N0M0	I	Moderate	-	No active disease at 15 mo follow-up
9	T4N2M0	III	Moderate	-	Died of metastatic diesease 18 mo postresection
10	T3N2M0	III	Moderate	-	No active disease at 18 mo follow-up
11	T2N0M0	I	Moderate	-	Died of cardiopulmonary complication postoperatively
12	T3N0M1	IV	Poor	-	Died of cardiopulmonary complication postoperatively
13	T3N1M0	III	Moderate	-	No active disease at 32 mo follow-up
14	T3N1M0	III	Moderate	-	No active disease at 20 mo follow-up
15	T3N0M0	II	Poor	-	No active disease at 16 mo follow-up
16	T3N1M0	III	Well	-	No active disease at 19 mo follow-up
17	T3N0M0	II	Well	+	No active disease at 30 mofollow-up
18	T3N1M0	III	Well	-	No active disease at 44 mo follow-up
19	T4N2M1	IV	Poor	-	Died of metastatic diesease 5 mo postresection
20	T4N2M1	IV	Poor	-	Died of metastatic diesease 4 mo postresection
21	T3N0M0	II	Moderate	-	Died of metastatic diesease 56 mo postresection
22	T4N1M1	IV	Moderate	-	Died of metastatic diesease 15 mo postresection
23	T4N1M0	III	Moderate	-	Died of cardiopulmonary complication postoperatively
24	T3N0M0	II	Poor	-	No active disease at 18 mo follow-up
25	T3N0M0	II	Moderate	-	No active disease at 16 mo follow-up
26	T4N1M0	III	Moderate	-	No active disease at 14 mo follow-up